Lobular carcinoma in situ (LCIS) is a rare condition where unusual cells are found in your lobules. These lobules are the small glands in your breasts that produce milk.
Even though the name includes the word "carcinoma" (which means cancer), LCIS is not actually breast cancer. The unusual cells in your breast glands are not malignant. Because they are "in situ" (which means "in its original place"), they do not grow into invasive cancer or spread from the lobules to other parts of your breast.
Having LCIS does not mean you are seriously ill right now. However, receiving this diagnosis does mean you have a higher risk of developing breast cancer in the future.
Doctors categorize lobular carcinoma in situ based on how the unusual cells look when viewed under a microscope:
Usually, LCIS does not cause any symptoms. Most people find out they have breast cancer when they feel a lump, but LCIS is different. It is typically discovered by a doctor while they are checking the results of a breast biopsy that was originally done for a completely different reason.
Scientists know that healthy cells in your lobules can turn into unusual cells because of changes in their genes. However, they are still not exactly sure what causes this change to happen in the first place.
While it does not happen often, LCIS has the potential to turn into lobular breast cancer or ductal carcinoma in situ (DCIS). Research shows that about 1 in 10 people with LCIS will develop one of these conditions. You should ask your doctor to explain what you should expect based on your specific case.
If a test shows unusual cells in your lobules, your doctor may ask for a second biopsy. This is done to find and remove any other unusual cells. A specialist called a pathologist will then look at these cells under a microscope to figure out exactly which type of LCIS you have.
The way you are treated depends on the specific type of LCIS you have. For example, if you have classic LCIS, your doctor might suggest "active surveillance" or preventive therapy. If you have florid or pleomorphic LCIS, you might need surgery.
This involves regular check-ups and tests to keep a close watch on your health. Your doctor might perform a breast exam every six months and will likely ask you to get a mammogram every year. They might also suggest extra tests, like a breast MRI scan.
The goal of preventive therapy is to stop the unusual cells in your lobules from ever turning into cancer. Common medications include:
Selective Estrogen Receptor Modulators (SERMs): Your doctor might suggest these if you have a higher risk of a specific type of cancer called ER-positive breast cancer.
Aromatase Inhibitors: These are similar to SERMs and are also used to help prevent or treat ER-positive breast cancer.
A surgeon might suggest a procedure if tests show you have pleomorphic or florid LCIS. Options include:
Your experience will depend on your specific situation and the type of LCIS you have. If you feel unsure, ask your doctor to explain exactly what is happening in your breast and go over your treatment options. Knowing your choices will help you feel more confident about your health plan.
Unfortunately, researchers do not know enough about LCIS yet to give a guaranteed way to prevent it. However, you can take these steps to lower your overall risk of breast problems:
Beyond eating well and exercising, you can stay proactive by:
Tender Palm Super-Speciality Hospital offers advanced Lobular Carcinoma in Situ (LCIS) treatment in Lucknow, India, at an affordable cost. We have a team of experienced oncologists and breast cancer specialists, known as some of the best doctors for managing high-risk breast conditions. We provide accurate diagnosis with advanced imaging and biopsy tests, personalized risk-reduction strategies, close surveillance, and treatment when required. Our team has decades of experience in successfully managing Lobular Carcinoma in Situ in Lucknow, India.
Call us at +91-9076972161
Email at care@tenderpalm.com